Law ❯ Securities Law ❯ Investor Rights ❯ Class Action

Lead Plaintiff

Veritone Admits Q3 2025 Revenue Accounting Errors and Draws Multiple Investor Lawsuits

The company says it misapplied ASC 606 rules, triggering restatement work and competing securities claims that could lead to regulatory review.

Investors File Securities Suit Over Graphic Packaging Inventory Problems

Multiple Plaintiff Firms Press Investors to Lead FS KKR Capital Securities Lawsuit

Multiple Firms Seek Lead Role in Securities Suit Over Commvault’s ARR Shortfall

Investors File Securities Suit Against Regencell as Firms Seek Lead Plaintiff

Gossamer Bio Faces Class Actions After Phase 3 PROSERA Misses Primary Endpoint

FS KKR Capital Sued in Securities Class Action as Firms Seek Lead Plaintiff

Oddity Tech Investors Face Monday Deadline To Seek Lead Role in Securities Case

Gossamer Bio Faces Securities Class Action After PROSERA Failure, 80% Stock Plunge

Rosen Law Firm Reminds PSIX Investors of May 19 Deadline to Seek Lead Plaintiff Role

Nektar Investors Face May 5 Deadline in Securities Suit Over REZOLVE-AA Trial Claims

Medpace Investors Urged to Seek Lead Role in Securities Suit Before June 8 Deadline

Camping World Investors Face May 11 Deadline in Securities Class Action

Soleno Therapeutics Investors Face May 5 Deadline to Seek Lead Role in Securities Class Action

Power Solutions Investors Face May 19 Deadline to Seek Lead Plaintiff Role

Investor Lawyers Press April Deadlines in Lakeland and Navan Securities Cases

Ramaco Resources Investors Get March 31 Cut-Off To Seek Lead Role In Securities Case

Camping World Sued in Federal Securities Class Action Over Inventory and Demand Claims

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO